10-Q 1 iknx-20180630x10q.htm 10-Q iknx_Current_Folio_10Q_for_Q2_Q3

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

(Mark One)

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended June 30, 2018

 

or

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Transition Period From                                to                                 .

 

Commission file number 000-25727

 

IKONICS CORPORATION

(Exact name of registrant as specified in its charter)

Minnesota

 

41-0730027

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. employer

identification no.)

 

 

 

4832 Grand Avenue

Duluth, Minnesota

 

55807

(Address of principal executive offices)

 

(Zip code)

(218) 628-2217

Registrant’s telephone number

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)  Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

 

Accelerated filer ☐

Non-accelerated filer ☐

 

Smaller reporting company ☒

 

 

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: Common Stock, $.10 par value per share - 1,983,553 shares outstanding as of August 1, 2018.

 

 

 


 

IKONICS Corporation

 

QUARTERLY REPORT ON FORM 10-Q

 

 

 

PAGE NO.

PART I. 

FINANCIAL INFORMATION

 

 

 

 

Item 1. 

 

Condensed Financial Statements:

 

 

 

 

 

 

 

Condensed Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017

1

 

 

 

 

 

 

Condensed Statements of Operations for the Three Months and Six Months Ended June 30, 2018 and 2017 (unaudited)

2

 

 

 

 

 

 

Condensed Statements of Cash Flows for the Six Months Ended June 30, 2018 and 2017 (unaudited)

3

 

 

 

 

 

 

Notes to Condensed Financial Statements (unaudited)

4

 

 

 

 

Item 2. 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12

 

 

 

 

Item 3. 

 

Quantitative and Qualitative Disclosures about Market Risk

19

 

 

 

 

Item 4. 

 

Controls and Procedures

19

 

 

 

PART II. 

OTHER INFORMATION

20

 

 

 

 

SIGNATURES

 

 

 

 

 

2


 

PART I - FINANCIAL INFORMATION

 

ITEM 1.  Condensed Financial Statements

 

IKONICS CORPORATION

CONDENSED BALANCE SHEETS

 

 

 

 

 

 

 

 

 

 

June 30,

 

December 31,

 

 

    

2018

    

2017

 

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,355,828

 

$

929,700

 

Short-term investments

 

 

2,920,000

 

 

2,895,000

 

Trade receivables, less allowances of $53,000 as of June 30, 2018 and                      December 31, 2017

 

 

1,868,913

 

 

2,190,260

 

Inventories

 

 

2,471,546

 

 

2,086,065

 

Prepaid expenses and other assets

 

 

184,426

 

 

168,242

 

Income taxes receivable

 

 

3,481

 

 

2,116

 

Total current assets

 

 

8,804,194

 

 

8,271,383

 

PROPERTY, PLANT, AND EQUIPMENT, at cost:

 

 

 

 

 

 

 

Land and building

 

 

9,366,400

 

 

9,207,790

 

Machinery and equipment

 

 

5,074,952

 

 

4,968,595

 

Office equipment

 

 

1,583,524

 

 

1,573,191

 

Vehicles

 

 

245,679

 

 

245,679

 

 

 

 

16,270,555

 

 

15,995,255

 

Less accumulated depreciation

 

 

(8,040,289)

 

 

(7,693,594)

 

Total property, plant, and equipment, at cost

 

 

8,230,266

 

 

8,301,661

 

INTANGIBLE ASSETS, less accumulated amortization of $137,686 as of June 30, 2018 and $174,991 as of December 31, 2017

 

 

370,844

 

 

351,186

 

Total assets

 

$

17,405,304

 

$

16,924,230

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

Current portion of long-term debt, net

 

$

126,422

 

$

130,899

 

Accounts payable

 

 

830,183

 

 

321,860

 

Accrued compensation

 

 

341,369

 

 

360,554

 

Other accrued liabilities

 

 

84,615

 

 

62,468

 

Total current liabilities

 

 

1,382,589

 

 

875,781

 

LONG-TERM LIABILITIES

 

 

 

 

 

 

 

Long-term debt, less current portion, net

 

 

2,886,874

 

 

2,946,518

 

Deferred income taxes

 

 

156,839

 

 

144,000

 

Total long-term liabilities

 

 

3,043,713

 

 

3,090,518

 

Total liabilities

 

 

4,426,302

 

 

3,966,299

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

Preferred stock, par value $.10 per share; authorized 250,000 shares; none issued

 

 

 —

 

 

 —

 

Common stock, par value $.10 per share; authorized 4,750,000 shares; issued and outstanding 1,983,553 shares as of June 30, 2018 and December 31, 2017

 

 

198,355

 

 

198,355

 

Additional paid-in capital

 

 

2,715,863

 

 

2,709,390

 

Retained earnings

 

 

10,064,784

 

 

10,050,186

 

Total stockholders’ equity

 

 

12,979,002

 

 

12,957,931

 

Total liabilities and stockholders' equity

 

$

17,405,304

 

$

16,924,230

 

 

See notes to condensed financial statements.

 

1


 

IKONICS CORPORATION

CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Three Months Ended

 

Six Months Ended

 

    

June 30,

 

June 30,

 

    

2018

    

2017

    

2018

    

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

NET SALES

 

$

4,634,177

 

$

4,685,361

 

$

8,705,655

 

$

8,314,353

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF GOODS SOLD

 

 

2,971,862

 

 

3,242,097

 

 

5,680,921

 

 

5,780,861

 

 

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

 

1,662,315

 

 

1,443,264

 

 

3,024,734

 

 

2,533,492

 

 

 

 

 

 

 

 

 

 

 

 

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

 

 

1,308,963

 

 

1,393,636

 

 

2,657,946

 

 

2,904,250

 

 

 

 

 

 

 

 

 

 

 

 

 

RESEARCH AND DEVELOPMENT EXPENSES

 

 

156,472

 

 

184,704

 

 

310,548

 

 

350,474

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM OPERATIONS

 

 

196,880

 

 

(135,076)

 

 

56,240

 

 

(721,232)

 

 

 

 

 

 

 

 

 

 

 

 

 

INTEREST EXPENSE

 

 

(23,807)

 

 

(20,826)

 

 

(43,742)

 

 

(41,643)

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER

 

 

11,805

 

 

5,902

 

 

21,226

 

 

11,055

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) BEFORE INCOME TAXES

 

 

184,878

 

 

(150,000)

 

 

33,724

 

 

(751,820)

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX EXPENSE (BENEFIT)

 

 

39,542

 

 

(44,934)

 

 

19,126

 

 

(267,857)

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

 

$

145,336

 

$

(105,066)

 

$

14,598

 

$

(483,963)

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.07

 

$

(0.05)

 

$

0.01

 

$

(0.24)

Diluted

 

$

0.07

 

$

(0.05)

 

$

0.01

 

$

(0.24)

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

1,983,553

 

 

2,018,466

 

 

1,983,553

 

 

2,018,609

Diluted

 

 

1,983,553

 

 

2,018,466

 

 

1,983,553

 

 

2,018,609

 

See notes to condensed financial statements.

2


 

IKONICS CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)

 

 

 

 

 

 

 

 

 

 

    

Six Months Ended

 

 

 

June 30,

 

 

 

2018

    

2017

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

Net income (loss)

 

$

14,598

 

$

(483,963)

 

Adjustments to reconcile net income (loss) to net cash provided by

 

 

 

 

 

 

 

Depreciation

 

 

395,787

 

 

421,412

 

Amortization

 

 

18,615

 

 

19,149

 

Stock based compensation

 

 

6,473

 

 

11,494

 

      Net gain on sale and disposal of property, plant and equipment

 

 

 —

 

 

(21,707)

 

Deferred income taxes

 

 

12,839

 

 

 —

 

Changes in working capital components:

 

 

 

 

 

 

 

Trade receivables

 

 

321,347

 

 

269,765

 

Inventories

 

 

(385,481)

 

 

(290,429)

 

Prepaid expenses and other assets

 

 

(16,184)

 

 

215,133

 

Income tax receivable

 

 

(1,365)

 

 

(207,854)

 

Accounts payable

 

 

508,323

 

 

144,409

 

Accrued expenses

 

 

2,962

 

 

(26,896)

 

Net cash provided by operating activities

 

 

877,914

 

 

50,513

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

Purchases of property, plant, and equipment

 

 

(324,392)

 

 

(134,086)

 

Proceeds from sale of property and equipment

 

 

 —

 

 

21,707

 

Purchases of intangible assets

 

 

(32,354)

 

 

(15,044)

 

Purchases of short-term investments

 

 

(2,920,000)

 

 

(1,915,000)

 

Proceeds on sale of short-term investments

 

 

2,895,000

 

 

2,266,000

 

Net cash provided by (used in) investing activities

 

 

(381,746)

 

 

223,577

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

Payments on long-term debt

 

 

(70,040)

 

 

(69,564)

 

Repurchase of common stock

 

 

 —

 

 

(15,038)

 

Proceeds from exercise of stock options

 

 

 —

 

 

1,885

 

Net cash used in financing activities

 

 

(70,040)

 

 

(82,717)

 

 

 

 

 

 

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

 

426,128

 

 

191,373

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

 

 

929,700

 

 

1,048,713

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

 

$

1,355,828

 

$

1,240,086

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

 

Cash paid for interest

 

$

36,711

 

$

35,776

 

    Cash paid for income taxes, net

 

$

7,652

 

$

60,003

 

 

See notes to condensed financial statements.

 

 

3


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

1.Basis of Presentation

 

The condensed balance sheet of IKONICS Corporation (the “Company”) as of June 30, 2018, and the related condensed statements of operations for the three and six months ended June 30, 2018 and 2017, and cash flows for the six months ended June 30, 2018 and 2017, have been prepared without being audited.

 

In the opinion of management, these statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of IKONICS Corporation as of June 30, 2018, and the results of operations and cash flows for all periods presented.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted.  Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

 

The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year.

 

2.Revenue

 

The Company’s significant accounting policies are detailed in “Note 1: Summary of Significant Accounting Policies” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.  In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, Topic 606. Revenue from Contracts with Customers (Topic 606), and in August 2015, FASB issued ASU

2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of Effective Date, which deferred the effective date of ASU 2014-09 by one year.  Topic 606 supersedes the revenue recognition requirements previously set forth in the Accounting Standards Codification (ASC) Topic 605, Revenue Recognition, and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services.

 

On January 1, 2018, the Company adopted Topic 606 for all customer contracts using the modified retrospective method.  The adoption of Topic 606 did not result in a change to revenue previously recognized under prior revenue recognition rules.  The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company does not expect the adoption of the new revenue standard to have a material impact to its operating results on an ongoing basis.  A majority of the Company’s sales revenue continues to be recognized when products are shipped from its manufacturing facility.  However, depending on the individual terms of the agreement with the customer, some sales revenue may be recognized when the goods arrive at the customer’s location, the point at which control transfers. 

 

Changes to the Company’s significant accounting policies as a result of adopting Topic 606 are discussed below:

 

Revenue recognition.  Revenue is measured based on consideration specified in the contract with a customer, adjusted for any applicable estimates of variable consideration and other factors affecting the transaction price, including noncash consideration, consideration paid or payable to customers and significant financing components.  While most of the Company’s revenue is contracted with customers through one-time purchase orders and short-term contracts, the Company does have long-term arrangements with certain customers. 

4


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

Revenue from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer. 

 

Individually promised goods and services in a contract are considered a distinct performance obligation and accounted for separately if the customer can benefit from the individual good or service on its own or with other resources that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.  When an arrangement includes multiple performance obligations, the consideration is allocated between the performance obligations in proportion to their estimated standalone selling price.  Costs related to products delivered are recognized in the period incurred, unless criteria for capitalization of costs are met. Costs of revenues consist primarily of direct labor, manufacturing overhead, materials and components.  The Company does not incur significant upfront costs to obtain a contract.  If costs to obtain a contract were to become material, the costs would be recorded as an asset and amortized to expense in a manner consistent with the related recognition of revenue.

 

The Company excludes government assessed and imposed taxes on revenue generating transactions that are invoiced to customers from revenue.  The Company includes freight billed to customers in revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of goods sold.

 

The timing of revenue recognition, billings and cash collections results in accounts receivable on the balance sheet.

 

Performance obligations.  A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.  A contract’s transaction price is allocated to each distinct performance obligation in proportion to its standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.  The Company’s various performance obligations and the timing or method of revenue recognition are discussed below: 

 

The Company sells its products to both distributors and end-users. Each unit of product delivered under a customer order represents a distinct and separate performance obligation as the customer can benefit from each unit on its own or with other resources that are readily available to the customer and each unit of product is separately identifiable from other products in the arrangement.

 

The transaction price for the Company’s products is the invoiced amount.  The Company does not have variable consideration in the form of refunds, credits, rebates, price concessions, pricing incentives or other items impacting transaction price.  The purchase order pricing in arrangements with customers is deemed to approximate standalone selling price; therefore, the Company does not need to allocate proceeds on a relative standalone selling price allocation between performance obligations.  The Company applies the practical expedient in paragraph 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.  There are no material obligations that extend beyond one year. 

 

Revenue is recognized when transfer of control occurs as defined by the terms in the customer agreement.  The Company immediately recognizes incidental items that are immaterial in the context of the contract.  The Company has applied the practical expedient in paragraph 606-10-25-16A and does not assess if immaterial items are promised goods or services.  The Company has also applied the practical expedient in paragraph

606-10-32-18 regarding the adjustment of the promised amount of consideration for the effects of a significant financing component when the customer pays for that good or service within one year or less, as the Company

5


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

does not have any significant financing components in its customer arrangements as payment is received at or shortly after the point of sale, generally thirty to ninety days.

 

The Company estimates returns based on an analysis of historical experience if the right to return products is granted to its customers.  The Company does not record a return asset as non-conforming products are generally not returned.  The Company’s return policy does not vary by geography.  The customer has no rotation or price protection rights.

 

Trade receivables.  Trade receivables include amounts invoiced and currently due from customers. The amounts due are stated at their net estimated realizable value.  The Company records an allowance for doubtful accounts to provide for the estimated amount of receivables that will not be collected. The allowance is based on a review of all outstanding amounts on an on-going basis. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considers a customer’s financial condition, credit history, and current economic conditions. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. Accounts are considered past due if payment is not received according to agreed-upon terms.

 

Sales commissions.  Sales commissions paid to sales representatives are eligible for capitalization as they are incremental costs that would not have been incurred without entering into a specific sales arrangement and are recoverable through the expected margin on the transaction.  The Company has elected to apply the practical expedient provided by ASC 340-40-25-4 and recognize the incremental costs of obtaining contracts as an expense when incurred, as the amortization period of the assets that would have otherwise been recognized is one year or less.  The Company records these costs in selling, general, and administrative expense.

 

Product warranties.   The Company offers warranties on various products and services. These warranties are assurance type warranties that are not sold on a standalone basis; therefore, they are not considered distinct performance obligations.  The Company estimates the costs that may be incurred under its warranties and records a liability in the amount of such costs at the time the revenue is recognized for the product sale. 

 

International revenue.  The Company markets its products to numerous countries in North America, Europe, Latin America, Asia and other parts of the world.  Foreign sales were approximately 28% of total sales during the first six months of 2018 compared to 34% of sales for the first six months of 2017.

 

3.Short-Term Investments

 

The Company’s $2.9 million of short-term investments at June 30, 2018 is comprised of twelve fully insured certificates of deposit with original maturities ranging from five to six months and interest rates ranging from 1.55% to 2.00%.

 

6


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

4.Inventories

 

The major components of inventories are as follows:

 

 

 

 

 

 

 

 

 

 

    

Jun 30, 2018

    

Dec 31, 2017

 

 

 

 

 

 

 

 

 

Raw materials

 

$

1,624,803

 

$

1,428,924

 

Work-in-progress

 

 

428,384

 

 

423,186

 

Finished goods

 

 

1,618,978

 

 

1,416,547

 

Reduction to LIFO cost

 

 

(1,200,619)

 

 

(1,182,592)

 

 

 

 

 

 

 

 

 

Total Inventories

 

$

2,471,546

 

$

2,086,065

 

 

 

5.Earnings Per Common Share (EPS)

 

Basic EPS is calculated using net income (loss) divided by the weighted average of common shares outstanding.  Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued.

 

Shares used in the calculation of diluted EPS are summarized below:

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

Jun 30, 2018

    

Jun 30, 2017

  

 

 

 

 

 

 

Weighted average common shares outstanding

 

1,983,553

 

2,018,466

 

Dilutive effect of stock options

 

 —

 

 —

 

Weighted average common and common equivalent shares outstanding

 

1,983,553

 

2,018,466

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

    

Jun 30, 2018

    

Jun 30, 2017

  

 

 

 

 

 

 

Weighted average common shares outstanding

 

1,983,553

 

2,018,609

 

Dilutive effect of stock options

 

 —

 

 —

 

Weighted average common and common equivalent shares outstanding

 

1,983,553

 

2,018,609

 

 

For the three and six months ended June 30, 2018, options to purchase all 18,000 shares of common stock with a weighted average exercise price of $13.22 were outstanding but were excluded from the computation of common shares equivalent because they were anti-dilutiveIf the Company was in a net income position for the three months ended June 30, 2017, all 18,168 options outstanding with a weighted average exercise price of $13.81 would have remained excluded from the computation of common share equivalents as the options were anti-dilutive.

 

If the Company was in a net income position for the first six months of 2017, 2,250 options outstanding with a weighted average exercise price of $8.91 would have been included as part of the weighted average common and common equivalent shares outstanding as the options would have been dilutive while 15,918 options

7


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

outstanding with a weighted average exercise price of $14.51 would have remained excluded as the options were anti-dilutive.   

 

 

6.Stock-Based Compensation

 

The Company maintains a stock incentive plan which authorizes the issuance of up to 442,750 shares of common stock. Of those shares, 18,000 were subject to outstanding options and 102,157 were reserved for future grants at June 30, 2018. The plan provides for granting eligible participants stock options or other stock awards, as described by the plan, at option prices ranging from 85% to 110% of fair market value at the date of grant.  Options granted expire up to seven years after the date of grant.  Such options generally become exercisable over a one- to three-year period.

 

The Company charged compensation cost of approximately $3,600 against income for the three months ended June 30, 2018 and approximately $6,000 for the three months ended June 30, 2017. For the first six months of 2018, the Company charged compensation cost of approximately $6,500 and approximately $11,500 for the same period in 2017.  As of June 30, 2018, there was approximately $19,800 of unrecognized compensation cost related to unvested share-based compensation awards. That cost is expected to be recognized over the next three years.

 

The Company receives a tax deduction for certain stock option exercises during the period in which the options are exercised, generally for the excess of the market price at the time the stock options are exercised over the exercise price of the options.

 

Proceeds from the exercise of 250 stock options were approximately $2,000 for the six months ended

June 30, 2017.  There were no options exercised during the six months ended June 30, 2018.    

 

The fair value of options granted during the six months ended June 30, 2018 and 2017 was estimated using the Black-Scholes option pricing model with the following assumptions:

 

 

 

 

 

 

 

 

    

2018

    

2017

 

Dividend yield

 

0%

 

0%

 

Expected volatility

 

40.0%

 

41.3%

 

Expected life of option

 

Five Years

 

Five Years

 

Risk-free interest rate

 

2.8%

 

1.8%

 

Fair value of each option on grant date

 

$ 3.38

 

$ 3.43

 

 

There were 2,750 and 2,250 options granted during each of the six months ended June 30, 2018 and 2017, respectively while 2,918 options expired during the six months ended June 30, 2018.

 

8


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

Stock option activity during the six months ended June 30, 2018 was as follows:

 

 

 

 

 

 

 

 

 

    

 

    

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

    

Shares

    

Price

 

Outstanding at January 1, 2018

 

18,168

 

$

13.81

 

Granted

 

2,750

 

 

8.63

 

Exercised

 

 —

 

 

 —

 

Expired and forfeited

 

(2,918)

 

 

12.56

 

Outstanding at June 30, 2018

 

18,000

 

$

13.22

 

Exercisable at June 30, 2018

 

12,247

 

$

15.09

 

 

The aggregate intrinsic value of all options outstanding and for those exercisable at June 30, 2018 was approximately $1,400 and $100, respectively.

 

 

7.Segment Information

 

The Company’s reportable segments are strategic business units that offer different products and have varied customer bases.  There are five reportable segments:  Domestic, Export, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS).  Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada.  IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States and Canada.  AMS provides sound deadening and weight reduction technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers.  DTX includes products and customers related to patented and proprietary inkjet technology used for mold texturing and prototyping. Export sells primarily the same products as Domestic and the IKONICS Imaging products not related to AMS or DTX. The accounting policies applied to determine the segment information are the same as those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

 

Management evaluates the performance of each segment based on the components of divisional income (loss).  Assets and liabilities are not allocated to segments, except for trade receivables which are allocated based on the previous segmentation.  Financial information with respect to the reportable segments follows:

 

For the three months ended June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

Export

 

Imaging

 

DTX

 

AMS

 

Unalloc.

 

Total

 

Net sales

 

$

1,991,978

 

$

1,207,881

 

$

868,966

 

$

94,322

 

$

471,030

 

$

 

$

4,634,177

 

Cost of goods sold

 

 

1,152,396

 

 

951,597

 

 

443,569

 

 

33,612

 

 

390,688

 

 

 

 

2,971,862

 

Gross profit

 

 

839,582

 

 

256,284

 

 

425,397

 

 

60,710

 

 

80,342

 

 

 

 

1,662,315

 

Selling, general and administrative*

 

 

310,483

 

 

138,930

 

 

236,612

 

 

32,596

 

 

97,476

 

 

492,866

 

 

1,308,963

 

Research and development*

 

 

 

 

 

 

 

 

 

 

 

 

156,472

 

 

156,472

 

Income (loss) from operations

 

$

529,099

 

$

117,354

 

$

188,785

 

$

28,114

 

$

(17,134)

 

$

(649,338)

 

$

196,880

 

 

9


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

For the three months ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Domestic

 

Export

 

Imaging

 

DTX

 

AMS

 

Unalloc.

 

Total

 

Net sales

 

$

1,816,956

 

$

1,372,092

 

$

943,055

 

$

471,244

 

$

82,014

 

$

 —

 

$

4,685,361

 

Cost of goods sold

 

 

1,034,059

 

 

1,096,279

 

 

453,213

 

 

358,937

 

 

299,609

 

 

 —

 

 

3,242,097

 

Gross profit (loss)

 

 

782,897

 

 

275,813

 

 

489,842

 

 

112,307

 

 

(217,595)

 

 

 

 

1,443,264

 

Selling, general and administrative*

 

 

334,071

 

 

189,741

 

 

253,746

 

 

50,861

 

 

104,325

 

 

460,892

 

 

1,393,636

 

Research and development*

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

184,704

 

 

184,704

 

Income (loss) from operations

 

$

448,826

 

$

86,072

 

$

236,096

 

$

61,446

 

$

(321,920)

 

$

(645,596)

 

$

(135,076)

 

 

For the six months ended June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

Export

 

Imaging

 

DTX

 

AMS

 

Unalloc.

 

Total

 

Net sales

 

$

3,336,458

 

$

2,366,221

 

$

1,926,304

 

$

182,988

 

$

893,684

 

$

 

$

8,705,655

 

Cost of goods sold

 

 

1,986,737

 

 

1,848,657

 

 

1,000,657

 

 

59,004

 

 

785,866

 

 

 

 

5,680,921

 

Gross profit

 

 

1,349,721

 

 

517,564

 

 

925,647

 

 

123,984

 

 

107,818

 

 

 

 

3,024,734

 

Selling, general and administrative*

 

 

619,617

 

 

260,558

 

 

516,205

 

 

67,448

 

 

182,260

 

 

1,011,858

 

 

2,657,946

 

Research and development*

 

 

 

 

 

 

 

 

 

 

 

 

310,548

 

 

310,548

 

Income (loss) from operations

 

$

730,104

 

$

257,006

 

$

409,442

 

$

56,536

 

$

(74,442)

 

$

(1,322,406)

 

$

56,240

 

 

For the six months ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Domestic

    

Export

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

 

Net sales

 

$

3,120,525

 

$

2,427,097

 

$

1,933,041

 

$

586,475

 

$

247,215

 

$

 —

 

$

8,314,353

 

Cost of goods sold

 

 

1,860,800

 

 

1,935,643

 

 

976,793

 

 

394,419

 

 

613,206

 

 

 —

 

 

5,780,861

 

Gross profit (loss)

 

 

1,259,725

 

 

491,454

 

 

956,248

 

 

192,056

 

 

(365,991)

 

 

 

 

2,533,492

 

Selling, general and administrative*

 

 

685,493

 

 

385,858

 

 

537,605

 

 

85,496

 

 

201,120

 

 

1,008,678

 

 

2,904,250

 

Research and development*

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

350,474

 

 

350,474

 

Income (loss) from operations

 

$

574,232

 

$

105,596

 

$

418,643

 

$

106,560

 

$

(567,111)

 

$

(1,359,152)

 

$

(721,232)

 

 


*The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.

 

Trade receivables by segment as of June 30, 2018 and December 31, 2017 were as follows:

 

 

 

 

 

 

 

 

 

 

    

Jun 30, 2018

    

Dec 31, 2017

 

 

 

 

 

 

 

 

 

Domestic

 

$

890,054

 

$

1,119,228

 

Export

 

 

333,074

 

 

558,872

 

IKONICS Imaging

 

 

263,351

 

 

238,813

 

DTX

 

 

44,380

 

 

64,278

 

AMS

 

 

343,251

 

 

238,848

 

Unallocated

 

 

(5,197)

 

 

(29,779)

 

 

 

 

 

 

 

 

 

Total

 

$

1,868,913

 

$

2,190,260

 

 

 

10


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

8.Income Taxes

 

The federal Tax Cut and Jobs Act of 2017 (the “Tax Reform Act”) was enacted December 22, 2017.  Effective January 1, 2018, the Tax Reform Act reduced statutory corporate income tax rates from 35% to 21% in addition to other tax changes including re-valuation of deferred tax assets and liabilities.  

 

For the first half of 2018, the Company realized an income tax expense of $19,000, or an effective rate of 56.7%, which reflects the new federal corporate rate of 21% versus the income tax benefit of $268,000 or an effective rate of 35.6%, for the first half of 2017. The Company’s increased effective rate for 2018 relates to the higher year-to-date pre-tax income generated and the related impact of an unfavorable provision to return true-up and non-deductible permanent items.  The 2017 first half tax benefit was due to the year-to-date net loss. The income tax provision for the 2018 and 2017 periods differ from the expected benefit due to credits for research and development and other non-deductible items.

 

The Company’s federal net operating loss carryforward and research and development credit carryover as of June 30, 2018 was $141,000 and $27,000, respectively, and will begin to expire in 2037.  The Company’s gross state net operating loss carryforwards and research and development credit carryover as of June 30, 2018 was $61,000 and $115,000, respectively and begin to expire in 2026. 

 

The valuation allowance balance of $91,000 at June 30, 2018, relates entirely to Minnesota research and development credit carryforwards that the Company does not expect to utilize and begin to expire in 2028. 

 

It has been the Company’s policy to recognize interest and penalties related to uncertain tax positions in income tax expense.  As of June 30, 2018 and December 31, 2017, there was no liability for unrecognized tax benefits.

 

As of June 30, 2018, with few exceptions, the Company is no longer subject to examination prior to tax year 2014.

 

 

 

11


 

IKONICS CORPORATION

 

The information presented below in Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended.  Statements that are not historical or current facts, including statements about beliefs and expectations, are forward-looking statements. These forward-looking statements include statements relating to our future plans and objectives and results. Such statements are subject to risks and uncertainties, including those discussed elsewhere in this report and under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2017, as updated in our subsequent reports filed with the SEC, which could cause actual results to differ materially from those projected.  Because actual results may differ, readers are cautioned not to place undue reliance on these forward-looking statements.

 

ITEM 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following management’s discussion and analysis focuses on those factors that had a material effect on the Company’s financial results of operations during the second quarter of 2018 and first six months of 2018, as well as the same periods of 2017.  It should be read in connection with the Company’s condensed unaudited financial statements and notes thereto included in this Form 10-Q.

 

Critical Accounting Estimates

 

The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America.  Therefore, the Company is required to make certain estimates, judgments and assumptions that the Company believes are reasonable based upon the information available.  These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented.  The accounting estimates, which IKONICS believes are the most critical to aid in fully understanding and evaluating its reported financial results, include the following:

 

Trade Receivables.  The Company performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by review of the current credit information.  The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon historical experience and any specific customer collection issues that have been identified.  While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that it will continue to experience the same collection history that has occurred in the past.  The general payment terms are net 30-45 days for domestic customers and net 30-90 days for foreign customers.  A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any given country.  At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency.  These balances are adjusted to each quarter or year-end spot rate in accordance with FASB ASC 830, Foreign Currency Matters.  The Company also maintains a provision for any customer related returns based upon historical experience of actual returns and any specifically identified product issues, refunds or credits.

 

Inventories.  Inventories are valued at the lower of cost or market value using the last in, first out (LIFO) method.  The Company monitors its inventory for obsolescence and records reductions from cost when required.

 

Income Taxes.    Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.  Deferred tax assets and liabilities are presented as long-term on a net basis.  The Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the

12


 

financial statements.  Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement.  The guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods.

 

Revenue.  In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, Topic 606. Revenue from Contracts with Customers (Topic 606), and in August 2015, FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of Effective Date, which deferred the effective date of ASU 2014-09 by one year.  Topic 606 supersedes the revenue recognition requirements previously set forth in the Accounting Standards Codification (ASC) Topic 605, Revenue Recognition, and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services.

 

On January 1, 2018, the Company adopted Topic 606 for all customer contracts using the modified retrospective method.  The adoption of Topic 606 did not result in a change to revenue previously recognized under prior revenue recognition rules.  The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company does not expect the adoption of the new revenue standard to have a material impact to its operating results on an ongoing basis.  A majority of the Company’s sales revenue continues to be recognized when products are shipped from its manufacturing facility.  However, depending on the individual terms of the agreement with the customer, some sales revenue may be recognized when the goods arrive at the customer’s location, the point at which control transfers. 

 

Changes to the Company’s significant accounting policies as a result of adopting Topic 606 are discussed below:

Revenue recognition.  Revenue is measured based on consideration specified in the contract with a customer, adjusted for any applicable estimates of variable consideration and other factors affecting the transaction price, including noncash consideration, consideration paid or payable to customers and significant financing components.  While most of the Company’s revenue is contracted with customers through one-time purchase orders and short-term contracts, the Company does have long-term arrangements with certain customers.  Revenue from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer. 

 

Individually promised goods and services in a contract are considered a distinct performance obligation and accounted for separately if the customer can benefit from the individual good or service on its own or with other resources that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.  When an arrangement includes multiple performance obligations, the consideration is allocated between the performance obligations in proportion to their estimated standalone selling price.  Costs related to products delivered are recognized in the period incurred, unless criteria for capitalization of costs are met. Costs of revenues consist primarily of direct labor, manufacturing overhead, materials and components.  The Company does not incur significant upfront costs to obtain a contract.  If costs to obtain a contract were to become material, the costs would be recorded as an asset and amortized to expense in a manner consistent with the related recognition of revenue.

 

The Company excludes governmental assessed and imposed taxes on revenue transactions that are invoiced to customers from revenue.  The Company includes freight billed to customers in revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of goods sold.

 

The timing of revenue recognition, billings and cash collections results in accounts receivable on the balance sheet.

 

Performance obligations.  A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.  A contract’s transaction price is allocated to each distinct performance obligation in

13


 

proportion to its standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied.  The Company’s various performance obligations and the timing or method of revenue recognition are discussed below: 

 

The Company sells its products to both distributors and end-users. Each unit of product delivered under a customer order represents a distinct and separate performance obligation as the customer can benefit from each unit on its own or with other resources that are readily available to the customer and each unit of product is separately identifiable from other products in the arrangement.

 

The transaction price for the Company’s products is the invoiced amount.  The Company does not have variable consideration in the form of refunds, credits, rebates, price concessions, pricing incentives or other items impacting transaction price.  The purchase order pricing in arrangements with customers is deemed to approximate standalone selling price; therefore, the Company does not need to allocate proceeds on a relative standalone selling price allocation between performance obligations.  The Company applies the practical expedient in paragraph 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less. There are no material obligations that extend beyond one year. 

 

Revenue is recognized when transfer of control occurs as defined by the terms in the customer agreement. The Company immediately recognizes incidental items that are immaterial in the context of the contract.  The Company has also applied the practical expedient in paragraph 606-10-32-18 regarding the adjustment of the promised amount of consideration for the effects of a significant financing component when the customer pays for that good or service within one year or less, as the Company does not have any significant financing components in its customer arrangements as payment is received at or shortly after the point of sale, generally thirty to ninety days.

 

The Company estimates returns based on an analysis of historical experience if the right to return products is granted to its customers.  The Company does not record a return asset as non-conforming products are generally not returned.  The Company’s return policy does not vary by geography.  The customer has no rotation or price protection rights.

 

Trade receivables.  Trade receivables include amounts invoiced and currently due from customers. The amounts due are stated at their net estimated realizable value.  The Company records an allowance for doubtful accounts to provide for the estimated amount of receivables that will not be collected. The allowance is based on a review of all outstanding amounts on an on-going basis. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considers a customer’s financial condition, credit history, and current economic conditions. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. Accounts are considered past due if payment is not received according to agreed-upon terms.

 

Sales commissions.  Sales commissions paid to sales representatives are eligible for capitalization as they are incremental costs that would not have been incurred without entering into a specific sales arrangement and are recoverable through the expected margin on the transaction.  The Company has elected to apply the practical expedient provided by ASC 340-40-25-4 and recognize the incremental costs of obtaining contracts as an expense when incurred, as the amortization period of the assets that would have otherwise been recognized is one year or less.  The Company records these costs in selling, general, and administrative expense.

 

Product warranties.   The Company offers warranties on various products and services. These warranties are assurance type warranties that are not sold on a standalone basis; therefore, they are not considered distinct performance obligations.  The Company estimates the costs that may be incurred under its warranties and records a liability in the amount of such costs at the time the revenue is recognized for the product sale. 

 

International revenue.   The Company markets its products to numerous countries in North America, Europe, Latin America, Asia and other parts of the world.  Foreign sales were approximately 28% of total sales during the first six months of 2018 compared to 34% of sales for the first six months of 2017. 

 

14


 

Results of Operations

 

Quarter Ended June 30, 2018 Compared to Quarter Ended June 30, 2017

 

Sales.    Sales decreased 1.1% during the second quarter of 2018 to $4.6 million, compared to $4.7 million during the same period in 2017.  Second quarter sales were unfavorably impacted by a $377,000, or 80.0%, DTX sales decrease as 2017 DTX sales benefitted from $320,000 in sales of two DTX printers.  There were no printer sales during the second quarter of 2018, but the Company expects DTX printer sales in the second half of 2018.  DTX consumable sales were also down in the second quarter of 2018 compared to the same period last year.  Export sales also realized a 12.0% sales decrease in the second quarter as sales fell from $1.4 million in 2017 to $1.2 million in 2018, due mainly to lower sales into Asia that is partially related to timing of sales, which are expected to occur later in 2018.  IKONICS Imaging sales decreased from $943,000 in the second quarter of 2017 to $869,000 in the second quarter of 2018.  The $74,000, or 7.9%, decrease in sales is related to lower sales of film products compared to the prior year.  Partially offsetting these sales decreases is a $389,000 AMS increase as sales grew from $82,000 during the second quarter of 2017 to $471,000 in the second quarter of 2018.  Most of this increase is related to increased sales to AMS’s largest customer who is expected to maintain similar sales levels for the remainder of 2018.  AMS sales during the second quarter of 2017 were unfavorably affected by a temporary decrease in orders from its largest customer.  Domestic also realized a $175,000 or 9.6% sales increase during the second quarter of 2018 compared to the same period last year from increased emulsion sales.     

 

Gross Profit.  Gross profit was $1.7 million, or 35.9% of sales, in the second quarter of 2018 compared to $1.4 million, or 30.8% of sales, for the same period in 2017. AMS increased sales volumes benefitted the 2018 second quarter gross margin as the AMS gross margin improved from a negative 265.3% in second quarter of 2017 to a positive 17.1% this quarter.  A large portion of the AMS cost structure is fixed, causing sales volumes to have a significant impact on its gross margin.  The 2018 second quarter DTX gross margin improved to 64.4% from 23.8% in the second quarter of 2017 as the 2017 second quarter gross margin was negatively affected by the sale of two low-margin printers.  The IKONICS Imaging gross margin decreased from 51.9% in the second quarter of 2017 to 49.0% this quarter due to a less favorable sales mix while 2018 second quarter gross margins for Domestic and Export where similar to the same period last year.

 

Selling, General and Administrative Expenses.  Selling, general and administrative expenses were $1.3 million, or 28.2% of sales, in the second quarter of 2018 compared to $1.4 million, or 29.7% of sales, for the same period in 2017.  The second quarter 2018 decrease in selling, general and administrative expense is related to the Company’s cost reduction initiative.  The Company realized lower travel, promotional, consulting and salary expenses. 

 

Research and Development Expenses.  Research and development expenses during the second quarter of 2018 were $156,000, or 3.4% of sales, versus $185,000, or 3.9% of sales, for the same period in 2017.  The decrease in 2018 second quarter costs is due to lower production trial expenses.  The Company incurred additional production trial expenses in second quarter of 2017 related to the development of its new SubTHAT! film product.

 

Interest Expense.  Interest expense for the second quarter of 2018 was $24,000 compared to interest expense of $21,000 during the second quarter of 2017.  The interest expense is related to a $3.4 million financing agreement the Company entered into during 2016 to finance the construction of a 27,300-square foot building and related equipment for use in the Company’s manufacture of sound deadening technology used in the aerospace industry and products consisting of etched composites, ceramics, glass and silicon wafers.

 

Income Taxes. For the second quarter of 2018, the Company realized an income tax expense of $40,000, or an effective rate of 21.4% which reflects the new federal rate of 21% enacted December 22, 2017 through the Tax Cut and Jobs Act, compared to the income tax benefit of $45,000, or an effective rate of 30%, for the same period in 2017.  The decrease in the quarterly effective tax rate for 2018 over 2017 is primarily due to the lower federal tax rate.  The income tax provision for the 2018 and 2017 periods differ from expected tax benefit due to unfavorable non-deductible items and generation of research and development tax credits.

 

15


 

Six Months Ended June 30, 2018 Compared to the Six Months Ended June 30, 2017

 

Sales.  Sales increased 4.7% during the first six months of 2018 to $8.7 million compared to $8.3 million during the same period in 2017.  AMS 2018 first half sales increased by $646,000, or 261.5%, compared to the same period last year as the Company realized increased sales from its largest customer as the customer maintained expected activity level for the entire 2018 period while AMS sales during the first six months of 2017 were unfavorable affected by a temporary decrease in orders from its largest customer.  Domestic sales also increased from $3.1 million in first six months of 2017 to $3.3 million in the first six months of 2018, a $216,000, or 6.9%, sales increase due to improved emulsion and film sales.  First half sales of 2018 were unfavorably impacted by a $403,000, or 68.8%, DTX sales decrease as 2017 DTX sales benefitted from $320,000 in sales of two DTX printers.  There were no printer sales during the first six months of 2018, but the Company expects DTX printer sales in the second half of 2018.  DTX consumable sales were also down in the first half of 2018 compared to the same period last year.  Export sales for the first six months of 2018 decreased by $61,000, or 2.5%, from the same period in 2017 to $2.4 million due to lower sales in Asia partially offset by improved sales into Europe and the Middle East.  IKONICS Imaging sales were similar for the first six months of 2018 and 2017. 

 

Gross profit was $3.0 million, or 34.7% of sales, in the first half of 2018 compared to $2.5 million, or 30.5% of sales, for the same period in 2017. AMS increased sales volumes benefitted the 2018 gross margin as the AMS gross margin improved from a negative 148.0% in first half of 2017 to a positive 12.1% in 2018.  A large portion of the AMS cost structure is fixed, causing sales volumes to have a significant impact on its gross margin.  The 2018 DTX gross margin improved to 67.8% from 32.7% in the first six months of 2017 as the 2017 gross margin was negatively affected by the sale of two low margin printers.  The IKONICS Imaging gross margin decreased from 49.5% in the first half of 2017 to 48.1% this quarter due to a less favorable sales mix while 2018 gross margin for Export improved from 20.2% in the first half of 2017 to 21.9% due to an increase of higher margin European sales.  The Domestic gross margin for the first half of the year was similar in 2018 and 2017.

 

Selling, General and Administrative Expenses.  Selling, general and administrative expenses were $2.7 million, or 30.5% of sales, in the first half of 2018 compared to $2.9 million, or 34.9% of sales, for the same period in 2017.  The 2018 decrease in selling, general and administrative expense is related to the Company’s cost reduction initiative.  The Company realized lower travel, promotional, consulting and salary expenses. 

 

Research and Development Expenses.  Research and development expenses during the first six months of 2018 were $311,000, or 3.6% of sales, versus $350,000, or 4.2% of sales, for the same period in 2017.  The decrease in 2018 costs is due to lower production trial expenses.  The Company incurred additional production trial expenses in 2017 related to the development of its new SubTHAT! film product.

 

Interest Expense.